The U.S. Food & Drug Administration’s Pulmonary Allergy Drugs Advisory Committee voted that the risk-benefit profile of GSK’s…
Articles by Iqra Mumal, MSc
The U.S. Food and Drug Administration (FDA) has approved Pulmonx’s Zephyr Endobronchial Valve, a device designed to treat…
A new study showed that 21% of chronic obstructive pulmonary disease (COPD) cases can be attributed to occupational exposures, particularly…
The U.K.’s National Institute for Health and Care Excellence (NICE) has updated its guidelines to include endobronchial valves as…
A new study highlights the significant global burden of chronic obstructive pulmonary disease (COPD) and asthma, and calls for more…
Results from Novartis’ FLASH clinical trial show that switching patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) from treatment with Seretide…
A new study has shown that a minimally invasive procedure involving one-way valves can improve lung function in patients with severe…
The risk of visits to the emergency room or hospitalization for acute exacerbations due to chronic obstructive pulmonary disease…